Literature DB >> 7461716

Physicochemical characterization of C3b receptors isolated from human erythrocytes by immunoprecipitation.

J Gerdes, H Stein.   

Abstract

A high yield of active C3b receptors was obtained by solubilizing human erythrocyte membranes with 2 M KBr, whereas other solubilization agents yielded no, or significantly less activity. Gel filtration of the KBr lysates revealed that the apparent molecular wieght of biologically active C3b receptor molecules was greater than 1 x 10(6). Immunoprecipitates prepared with radio-iodinated KBr lysates and anti-C3 receptor sera (AC3RS) were subjected to sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) or sodium dodecyl gel filtration. Unreduced SDS-PAGE and gel filtration profiles showed three predominant peaks with apparent mol. wts of 1--1.3 x 10(6), 80,000 and 60,000. Whereas the high mol. wt component decreased only slightly after reduction, the 80,000 and 60,000 mol. wt components disappeared and two new peaks with apparent mol. wts of 38,000 and 18,000 appeared in SDS-PAGE profiles. Although the high mol. wt component present in reduced SDS-PAGE profiles was detectable in some of the control experiments, none of the other peaks could be precipitated with control sera, and these components could be demonstrated only when KBr lysates of C3b receptor-positive erythrocytes and AC3RS that were able to inhibit ligand binding of the C3b receptors were used for precipitation. These findings suggest that (a) the C3b receptor of human erythrocytes in its biologically active state is a macromolecule with an apparent mol. wt higher than 1 x 10(6) and (b) the protein moiety consists predominantly of non-covalently linked protein molecules with apparent mol wts of 80,000 and 60,000. These protein molecules are composed of disulphide-bridged polypeptide chains with apparent mol. wts of 38,000 and 18,000.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7461716      PMCID: PMC1458288     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  15 in total

1.  C3 receptors on lymphoid cells: isolation of active membrane fragments and solubilization of receptor complexes.

Authors:  M P Dierich; R A Reisfeld
Journal:  J Immunol       Date:  1975-06       Impact factor: 5.422

2.  The immune-adherence phenomenon; an immunologically specific reaction between microorganisms and erythrocytes leading to enhanced phagocytosis.

Authors:  R A NELSON
Journal:  Science       Date:  1953-12-18       Impact factor: 47.728

3.  The complexity of immunohistochemical staining pattern of Hodgkin and Sternberg-reed cells--demonstration of immunoglobulin, albumin, alpha1-antichymotrypsin and lysozyme.

Authors:  C S Papadimitriou; H Stein; K Lennert
Journal:  Int J Cancer       Date:  1978-05-15       Impact factor: 7.396

4.  Human monocytes: distinct receptor sites for the third component of complement and for immunoglobulin G.

Authors:  H Huber; M J Polley; W D Linscott; H H Fudenberg; H J Müller-Eberhard
Journal:  Science       Date:  1968-12-13       Impact factor: 47.728

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent.

Authors:  A E Bolton; W M Hunter
Journal:  Biochem J       Date:  1973-07       Impact factor: 3.857

7.  Complement receptor binding of C3b-coated cells treated with C3b inactivator, beta 1H globulin and trypsin.

Authors:  J R Carlo; S Ruddy; E J Studer; D H Conrad
Journal:  J Immunol       Date:  1979-08       Impact factor: 5.422

8.  Specificity of human lymphocyte complement receptors.

Authors:  G D Ross; M J Polley
Journal:  J Exp Med       Date:  1975-05-01       Impact factor: 14.307

9.  Two different complement receptors on human lymphocytes. One specific for C3b and one specific for C3b inactivator-cleaved C3b.

Authors:  G D Ross; M J Polley; E M Rabellino; H M Grey
Journal:  J Exp Med       Date:  1973-10-01       Impact factor: 14.307

10.  Receptors for complement of leukocytes.

Authors:  W H Lay; V Nussenzweig
Journal:  J Exp Med       Date:  1968-11-01       Impact factor: 14.307

View more
  5 in total

1.  Inhibition of phagocytosis of complement C3- or immunoglobulin G-coated particles and of C3bi binding by monoclonal antibodies to a monocyte-granulocyte membrane glycoprotein (Mol).

Authors:  M A Arnaout; R F Todd; N Dana; J Melamed; S F Schlossman; H R Colten
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

2.  Solubilization of an activity regulating C3b function from Raji cell membranes.

Authors:  P Carlson; S Ruddy; D H Conrad
Journal:  Immunology       Date:  1982-05       Impact factor: 7.397

3.  Immunohistological demonstration and physiochemical characterization of C3 receptors of normal and neoplastic lymphoid cells.

Authors:  J Gerdes; H Stein
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

4.  Human complement (C3b) receptors defined by a mouse monoclonal antibody.

Authors:  J Gerdes; M Naiem; D Y Mason; H Stein
Journal:  Immunology       Date:  1982-04       Impact factor: 7.397

5.  Deficiency of a surface membrane glycoprotein (Mo1) in man.

Authors:  N Dana; R F Todd; J Pitt; T A Springer; M A Arnaout
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.